Human medicines European public assessment report (EPAR): Olanzapine Teva, olanzapine, Date of authorisation: 12/12/2007, Revision: 32, Status: Authorised

Human medicines European public assessment report (EPAR): Olanzapine Teva, olanzapine, Date of authorisation: 12/12/2007, Revision: 32, Status: Authorised

Opinion/decision on a Paediatric investigation plan (PIP): Rinvoq, upadacitinib, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Skin and subcutaneous tissue disorders, PIP number: P/0079/2024

Opinion/decision on a Paediatric investigation plan (PIP): Rinvoq, upadacitinib, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Skin and subcutaneous tissue disorders, PIP number: P/0079/2024

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.